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Abstract 
Small intestinal function is critical to digestive health and patients believe an abnormal 
reaction to food is responsible for many of their symptoms. Despite this, our ability to 
assess disturbed function in clinical practice has been limited, particularly after ingestion 
of the complex nutrients which make up normal food. Recent advances in both wireless 
capsules and magnetic resonance imaging have provided new insights. This review will 
briefly describe the limitations of past techniques and focus on how these newer 
techniques  are changing our understanding, particularly of how patients’ gastrointestinal 
tracts respond to food. 
Key words: Magnetic Resonance Imaging, small intestine, function, food, 
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Key Points 
 Understanding of how the small intestine responds to normal mixed nutrient 
foods has been limited by difficulties in access 
 This review outlines advances in non-invasive imaging, both endoscopic and 
magnetic resonance imaging which have enhanced our understanding 
 There is a wide range of response to different foods which may underlie some of 
the food intolerances our patients report 
 
Introduction 
Our understanding of functional gastrointestinal diseases is limited by our ability to 
assess function and nowhere it that better illustrated than in the small bowel. Despite 
this being a vital organ its inaccessibility has markedly limited studies, particularly of 
how we process complex meals. When new technologies become available there are 
many important questions we can start to ask. 
The stimulus for this review has been a burgeoning of new data derived from a range of 
novel patient acceptable ways of assessing function. The focus of this review will be on 
new methods especially MRI which have opened up the area, allowing the study of 
responses to complex mixed nutrient meals and in both healthy volunteers and patients. 
 
The key functions of the small intestine are to receive acidic gastric chyme, neutralise 
the acid and mix it with bile to optimise the conditions for pancreatic and intestinal 
enzymes to allow digestion and absorption of complex nutrients.  
While barium contrast radiology gives excellent definition of anatomy  
it is a poor way of assessing function as the barium suspension used lacks normal 
nutrients.  
Intestinal perfusion techniques 
Assessing absorption / secretion has been performed using intestinal perfusion. This 
requires the passage of multi-lumen tubes into the intestine through which test solutions 
incorporating an non-absorbable marker, usually polyethylene glycol (PEG) are pumped 
and 20-30 cm further down the intestine the solutions are aspirated. Knowing flow and 
the dilution of the marker an increase or decrease in flow due to absorption or secretion 
can be calculated. Such studies have demonstrated the principles of absorption showing 
the sodium dependence of active sugar and amino acid absorption and also that water 
absorption is largely due to active  sodium and sugar absorption with an associated 
passive water flux1. The requirement of aspiration up very fine tubes (3-4mm internal 
diameter) limits these studies to low viscosity solutions. Very few patient studies have 
been done, possibly because the prolonged intubation needed is uncomfortable and the 
tube’s presence alters what is being measured, stimulating both secretion and motility  2 
3. Furthermore to facilitate aspiration unphysiological flow rates of around 20ml/ min  are 
used which are much greater than  normal  flow which is around 2 ml/min in fed state4. 
Measuring motility using water perfused intestinal manometers has similar limitations to  
perfusion studies though the tubes are finer and better tolerated. Such studies have 
clearly identified abnormalities of the migrating motor complex and diseases where this 
is abnormal e.g. showing decreased frequency and regularity of the migrating motor 
complex in pseudo-obstruction due to scleroderma. However such clear results are rare 
and most cases  of functional GI disease, especially IBS, show inconsistent abnormalities 
5. Although quantitative 24 hour studies have shown some increase in frequency and 
amplitude of intestinal pressure waves in irritable bowel syndrome with diarrhoea (IBS–
D) most IBS patients have values with the normal range 6 and  the technique is not 
widely used in clinical practice. 
Breath tests to evaluate mucosal function and transit  
The breath tests based on the fermentation of unabsorbed carbohydrate by colonic 
bacteria provided a technique which was easy to apply to large numbers of patients and 
were initially enthusiastically adopted though recently recognition of the many limitations 
particularly of the lactulose and fructose breath hydrogen test including their very poor 
reproducibility 7 means this enthusiasm has waned.   
Lactose breath hydrogen test  
This was the earliest breath test to be introduced to clinical practice and remains widely 
used though in some laboratories it has been replaced by the more convenient genetic 
test8. It assesses the rise in breath hydrogen  after ingesting 50g of lactose which occurs 
when malabsorbed lactose enters the colon.  This proves a good predictor of response in 
practice since it simulates real life e.g. milk drinking  and the signal measured assessed 
changes in the colon which caused relevant symptoms such as flatulence and diarrhoea. 
Xylose breath test 
D-xylose is a pentameric monosaccharide which is absorbed unchanged by an active 
sodium dependent transporter in  the upper small bowel  mucosa. Around 50% of 
absorbed D-xylose is rapidly excreted in the urine.  Absorption is limited allowing its 
urinary excretion  in the 5 hours following ingestion of 25 g to be used as a measure of 
small bowel function 9. Excretion of >5 g is normal while subjects with small bowel 
disease such as celiac disease excrete around 1-2 g. Collecting urine is inconvenient and 
often incomplete, so a serum xylose at 1 hour is often used and a level <25 mg/dl 
considered diagnostic of malabsorption with high sensitivity and specificity (91% and 
98% respectively) 9. These tests of intestinal function were developed at a time when 
obtaining duodenal biopsies required intubation under radiological screening and are 
rarely performed now that more specific diagnoses of the causes of malabsorption  can 
so readily be made by endoscopic duodenal biopsies.  
Lactulose breath test to measure transit 
Lactulose, being a disaccharide which cannot be digested by any human produces a 
steep rise in breath hydrogen on entering the colon, the timing of which has been used 
as a measure of small bowel transit. It depends on the rapid production of hydrogen (6-8 
min after direct infusion into caecum via orocaecal tube 10) which is true in most 
individuals, though a minority don’t produce  detectable hydrogen which is consumed via 
alternative pathways to yield methane, hydrogen sulphide or acetate. The quantitative 
response differs between individuals since it depends on their unique microbiota. These 
in turn depend on diet as seen by the fact that prefeeding with lactulose has been shown 
to increase the enzymes needed to ferment lactulose (b-galactosidase) 11. One of its 
limitations is that it alters what is being assessed, since like lactose in a lactose 
malabsorbing patient, it induces water secretion and distension of the small bowel 12 with 
secondary acceleration of transit13.   
 
Scintigraphic assessment of small bowel transit 
Incorporating radio-isotope into a test meal allows assessment of when isotope moves 
from the confines of the terminal ileum into the larger volume of the caecum and 
ascending colon, though this is inevitably some what subjective. This subjectivity can be 
reduced by measuring the % of the dose that has entered the colon at intervals and 
from extrapolating the  plotted curves the time for 50% of isotope to enter can be 
estimated. The difference  from the time to 50% gastric emptying then gives a measure 
of small bowel transit. Unlike lactulose the isotope has no effect on transit and the 
method does not depend on the microbiota.  Its has been used to show delayed small 
bowel transit in chronic intestinal pseudo-obstruction14 and  the acceleration of small 
bowel transit by bran15. While this has been used to assess drug effects13;16-19 it has not 
been widely adopted clinically since isolated disorders of small bowel transit are 
uncommon 18 and to some extent has been replaced by wireless capsule which avoids 
exposure to ionising radiation. 
 
Assessment of abnormalities of microbiota in small intestine 
The earliest clinical studies used jejunal aspirates to look for faecal organisms and 
concluded that these were usually associated with blind loops including jejunal 
diverticulae and surgically created “blind loops” which allowed colonic conditions to 
develop20. Subsequent studies showed that similar abnormal growth of organisms 
capable of deconjugating bile salts as assessed by the 14CO2 glycocholate breath test 
could also be detected in patients with impaired motility and absence of the migrating 
motor complex21. Numerous studies make it clear that normal commensals of the 
oropharyngeal  cavity  including members of the Streptococcus , Staphylococcus 
Lactobacillus , Neisseria , Veillonella  and  Corynebacterium families will be detected in 
the small bowel if qastric acid is absent due to proton pump therapy, gastric atropy or 
other diseases such as cirrhosis. Prospective studies suggest that prolonged PPI therapy 
can increase SIBO and is associated with vague abdominal symptoms such as bloating 
and flatulence22. The presence of fecal microbiota including coliforms and Bacteroides 
which require a microaerophilic environment may indicate more severe abnormalities 
and also be associated with evidence of damage to the mucosa and frank malabsorption. 
 14C-labelled xylose was also used as a non-invasive method to show small intestinal 
bacteria overgrowth (SIBO) and performed well compared to jejunal aspiration 23. 
However 14C has a half life of 100,000 years and is retained within the body so the 
radiation exposure  is unacceptable and these tests are no longer used though 13C –
xylose test is available. Intubation is impracticable in normal clinical practice and most 
centres will now use duodenal aspirate taken at endoscopy. At the Mayo clinic the 
criteria for abnormality are >105 colony forming units(cfu) /ml  or counts of anaerobic 
organisms of > 104 cfu / ml, the lower threshold recognising that anaerobic organisms 
represent a more abnormal state and are more likely to be associated with disease24. 
Lactulose breath hydrogen test to detect small intestinal bacterial overgrowth  
 Quantitative culture of intestinal aspirates requires samples to  be transported 
anerobically and rapidly processed which is very demanding in terms of time and effort 
so simpler alternatives would be attractive.  
Early reports suggested that small intestinal bacterial overgrowth (SIBO) could be 
detected by the presence of an abnormal lactulose breath hydrogen test (LBHTs). IBS 
patients were reported as more likely to show an abnormal LBHT with either 1) a rise in 
breath hydrogen <90 minutes after ingesting 10g of lactulose in 240ml of water or 2) a 
rise > 20ppm within 180 minutes or 3) the presence of two distinct peaks. However 
subsequent larger studies failed to show any difference between healthy controls and 
IBS patients using such criteria 25 26;27. A recent improvement in the  lactulose breath 
hydrogen test incorporating  a scintigraphic marker of caecal arrival of the lactulose 
suggested that most case of early rise in breath hydrogen were due to fast orocaecal 
transit28.  The proportion of IBS who show a breath hydrogen rise before caecal arrival 
depends on the thresholds used. Using a 20ppm threshold suggests only 3% of IBS and 
no healthy controls have SIBO but this rises to 17% of patients and no controls if 10ppm 
is used29. When the more demanding criteria of  jejunal aspirates  having >105 
organisms /ml is used only 4% of IBS have small intestinal bacterial overgrowth25.   If 
less stringent criteria of >5X 103 /ml are used  then 12% of controls and 43% of IBS 
patients meet criteria though this may reflect greater proton pump utilisation in IBS 
which is associated with similar increases in small bowel organisms. Validation against 
jejunal aspirate has only rarely been performed but suggests the LBHT performs poorly, 
with low sensitivity and specificity 30. 
The small benefit seen with rifaximin treatment cannot be used as evidence of the 
importance of SIBO since it may reflect changes in the colon rather than small bowel so 
the role of breath testing for SIBO in IBS remains unclear 31. More direct studies on 
microbiota currently being done using small bowel mucosal biopsies for culture and DNA-
based assessments may answer these potentially important questions.  
Glucose breath hydrogen test 
Measuring the breath hydrogen response after ingesting 50 g of glucose  has been  
widely used and is more sensitive in detecting small intestinal bacterial overgrowth than 
the 14C-labelled xylose breath test 32. However the performance of these tests requires 
organisms which ferment glucose to hydrogen and depends on the precise clinical groups 
studied.  Direct comparison with aspirates suggests glucose breath hydrogen test has 
poor sensitivity, as low as 27% in some series30. Further more recent studies show poor 
correlation between bacterial numbers either by culture or direct DNA-based assessment 
and breath hydrogen 33. Fast transit to the colon as shown by simultaneous scintigraphy  
is a common cause of false positives after gastric surgery 34. 
Assessing  gas in the small bowel 
Few imaging studies have examined this owing to the overlap of small bowel and colon 
making it difficult to precisely allocate gas bubbles to gut regions. One study using CT 
scanning showed that in healthy subjects the gut contained a median(interquartile 
range) of 95(71-141)ml of which 68(58-83)% was in the colon leaving about 1/3rd in the 
small bowel, mostly in small bubbles containing < 6 ml.  Around 5% of the total gas lay 
in the region of the terminal ileum, which is where bacterial fermentation of poorly 
absorbed dietary residue is most likely given that the terminal ileum contains around 107 
organisms per ml.  How important this is remains unclear since there was no difference 
in small bowel gas in patients with FGIDs compared to healthy controls35. 
A novel gas sensing radio-pill, 25mm long and 9.8mm  in diameter which can detect 
methane, carbon dioxide, hydrogen and oxygen has recently been developed and used 
to study fermentation of carbohydrate in the gut 36. The oxygen signal falls rapidly after 
leaving the stomach and its arrival in the anaerobic colon is readily detected so in theory 
it should be able to detect fermentation in the small bowel suggestive of SIBO. Results in 
large numbers of IBS patients are awaited with interest. 
Wireless capsule telemetry 
The idea of using pressure and pH sensitive pills which could be ingested and pass 
throughout the gut is not new, being first developed in the 1960s37. However 
improvements in electronics have permitted the production of much improved devices 
allowing both endoscopy as well as assessment of pressure, pH and temperature38;39.  
The SmartPill capsule measures 26 mm x 13 mm making it relatively easy to swallow 
however its size means that it is likely to require a migrating motor complex to push it 
through the pylorus. This passage can be easily detected by the marked change in pH, 
being  around 1-2 in the fasted stomach rising to 5-6 on entering the duodenum. The pH 
thereafter rises steadily reaching around 7-8, driven by active H+/ HCO3- exchange in the 
terminal ileum.  The entry into the colon is signalled by the fall in pH to around 5-6 in 
the ascending colon which contains up to 60mEq/l of short chain fatty acids. This allows 
assessment of small bowel transit but it main application has been to assess colonic 
transit and motility in constipation. When applied to patients with constipation or nausea 
the finding of delayed small bowel transit  may be useful in indicating a more generalised 
disorder suggestive of panenteric dysmotility 40.  
Endoluminal image analysis to assess small bowel motility 
It is a major problem that intubation to perform manometry is stressful and that this 
undoubtedly alters both gastric and small bowel motility. A novel approach, which largely 
avoids this problem, has been to use capsule endoscopy to non-invasively quantify wall 
movements. A study of patients with manometrically diagnosed pseudo-obstruction 
compared with health controls showed the patients had less phasic luminal closures and 
more images showing no movement. It also identified a group of symptomatic patients 
who did not show manometric abnormalities yet did have abnormalities identified with 
the new technique 41. Scoring the many thousands of images is very time consuming but 
a subsequent much larger series of 80 FGID patients using sophisticated automated 
image analysis showed that the method could identify around 29% with abnormalities 
around half having  hypodynamic and the other half hyperdynamic motility42.  
Magnetic tracking System 
Magnet Tracking System(MTS-1) is a novel technique involving tracking the movement 
through the gastrointestinal tract of a   small magnetic pill (dimensions: 6 × 15 mm, 
weight: 0.9 g, density: 1.8 g cm-3) 43. Its movement from stomach to small intestine 
can be determined from the cessation of regular 3/ minute movements due to gastric 
contractions. Ileocecal passage, which was identified as cessation of the 8-10 min-1 
contraction frequency of the small intestine is more problematic, as in the ileum 
contractions are fewer and more irregular. The most unexpected finding using this 
technique is that more than half the distance covered during the first two hours in the 
small intestine is due to fast movements which only occupy 5% of the time. This was 
true both fasting and fed 44. The MMC may well account for rapid fasting movements but 
the large rapid movements during feeding are unexpected. However these may be 
important in spreading chime along the small bowel to speed up absorption.  
Exactly the role of this technique in clinical practice or research remains unclear, 
however measuring transit alone is of limited value and usually needs to be combined 
with assessments of other small bowel functions such as absorption / secretion. 
Magnetic Resonance Imaging of small bowel water 
Clinical use 
Modern imaging techniques, which allow high quality images to be obtained within a few 
hundred milliseconds, together with the lack of ionising radiation have made MRI a very 
attractive way of assessing small bowel anatomy in clinical practice. This is particularly 
true for patients with Crohn’s disease, who often require repeated imaging over a life 
time, which in the past has exposed them to potential harmful doses of radiation. 
However the use of large doses of osmotic agents such as mannitol, while providing 
excellent anatomical definition of mucosal pathology does disturb digestive function and 
a rather different technique using the undisturbed bowel is required to assess function.  
Measuring small bowel water content 
The technique of MRI utilises the high concentration of hydrogen protons in the body and 
their magnetic properties when placed in a powerful magnetic field. The protons are 
excited by a radiofrequency excitation pulse and this energy is then re-emitted and 
analysed. Since the frequencies emitted depend on the magnetic field strength, spatial 
information can be encoded using time varying magnetic field gradients.  Different 
contrast in the images can be acquired using different timings and combinations of the 
radiofrequency electromagnetic waves used to excite the protons with the magnetic field 
gradients used to encode positional information.  This is because the chemical and 
physical environment of the protons effects how fast the signal decays and returns to 
equilibrium.  This decay and return to equilibrium of the MRI signal are characterised by 
the relaxation parameters T1 (return to equilibrium) and T2 (signal decay). 
The liquid in the small bowel can be assessed with a heavily T2-weighted single shot, 
fast spin echo MRI sequence (similar to that used for magnetic  resonance 
cholangiopancreatography [MRCP])to acquire 24 coronal images, with in-plane resolution 
interpolated to 0.78 mm x 0.78 mm and a slice thickness of 7 mm in a single breath-
hold . This sequence yields high-intensity signals from areas with non-viscous (‘free’) 
fluid and little signal from body tissues45 (Figure 1A). This sequence and analysis method 
to measure the volume of small bowel ‘free’ water has been validated using an infusion 
of known amounts of a mannitol-saline solution, known from perfusion studies to show 
no net absorption or secretion46.  The mannitol-saline solution was instilled (via a naso-
duodenal tube) in boluses of 40ml up to a total of 320 ml and the resulting images used 
to assess the volume. The exclusion of other (non fluid) tissue was achieved by using the 
signal intensity from the cerebrospinal fluid to calculate a cut off, excluding all pixels 
with values below this threshold. The clearly identifiable gallbladder, kidneys, bladder, 
stomach and large mesenteric vessels were then excluded manually. The threshold was 
optimised to give the best correlation of measured with infused volume and this was 
then validated on a second set of data (Figure 1B).  
This validated method has subsequently been used to define the changes in small bowel 
volume during digestion of a range of different components of food.  
Osmotic effect of poorly absorbed solutes 
Lactose intolerance has been well recognised for over 50 years as a trigger of IBS like 
symptoms. Intubation studies using intestinal aspirates obtained after ingestion of 50 g 
lactose in 180 ml of water showed considerable dilution of non-absorbable marker, 
indicating that approximately 1600 ml of water entered the small bowel, driven by the 
low sodium and hypertonicity of the ingested solution 47. A similar secretion has been 
documented using MRI.  Studies comparing an iso-osmolar mannitol solution (17.5 g in 
350 ml water) with an iso-osmolar glucose solution (17.5 g glucose in 350ml water 
showed both solutions emptied rapidly from the stomach and 40 minutes after ingestion 
250 ml of the glucose and 276 ml of the mannitol solution had emptied into the small 
bowel. While the glucose solution was rapidly absorbed after mannitol it peaked at over 
4 times baseline at 40 minutes (Figure 2) 48. This peak is 50ml higher than the sum of 
the volume emptied from the stomach plus the baseline value, indicating a net secretion 
induced by the mannitol. This confirms previous perfusion studies but without the need 
for intubation, making such studies much easier to perform. The secretory effect of 
mannitol was exploited as bowel preparation for colonoscopy before this was superseded 
by the even more effective polyethylene glycol and electrolyte mixtures now used. MRI 
studies showed that Moviprep, a PEG solution containing sodium chloride, sulphate and 
ascorbate caused a rapid increase in SBWC, from a baseline of 80-100ml rising to peak 
around 650 ml after 1 l of Moviprep. 49 (Figure 3). There was also a rapid transfer of fluid 
to the colon which showed as a much brighter image with an associated rise in T2. The 
effect of mannitol on the colon was much less apparent and, at the dose used, the 
colonic images changed surprisingly little, indicating that most of the mannitol was 
fermented and the resulting SCFAs absorbed along with water. 
Assessment of digestion of complex foods 
Most food we eat is not composed of simple solutions but complex mixtures of liquid and 
solid. Sampling these using intestinal tubes is virtually impossible but MRI allows a non-
invasive assessment of fluid fluxes, intestinal distension and entry of meal residue into 
the colon with subsequent fermentation, all features which can be linked to a range of 
symptoms described by patients with FGIDs.   
Carbohydrate, derived from polymers used by plants to store energy such as wheat, rice, 
potatoes and other tubers, is a dominant part of most patient’s diets. Cooked rice is a 
particularly well tolerated food, being rapidly and fairly completely absorbed as shown by 
breath hydrogen testing50. We have used  220 g cooked rice as part of a mixed nutrient 
standard test meal combined with a 100 ml orange juice, jam and bran flakes  providing 
362 kcal. After ingestion the changes in SBWC are biphasic. The gastric images show 
that the liquid phase empties faster than the solid. The liquid contains glucose, fructose 
and sucrose which are rapidly absorbed causing SBWC to fall to a nadir at 90 minutes 
post ingestion (Figure 4). The SBWC then rises in the later phase when the rice and bran 
enter the small bowel. The two lines show the meal with and without the bran, which 
increased SBWC. Bran also shortened transit from duodenum to caecum, implying an 
increased flow due to stimulation of secretion 48. This effect was more marked in females 
than males, though why this should be so is unclear. An earlier scintigraphic study using 
an identical protocol had shown similarly accelerated transit15 but unlike the MRI study 
could make no inferences about the cause, which demonstrates the power of the new 
technique compared with the old one. 
Gastrointestinal response to FODMAPs 
The recognition that poorly absorbed but rapidly fermentable dietary carbohydrate, so 
called FOMAPs (fermentable oligo-di- and mono-saccharide and polyhydric alcohols) was 
responsible for at least some of the symptoms of the ubiquitous irritable bowel 
syndrome51 has led to a substantial improvement in the management of IBS. 
Understanding exactly how FODMAPs cause symptoms requires imaging after a 
provocative meal containing FODMAPs.  MRI studies showed clearly that, while the 
poorly absorbed but osmotically active monomer, fructose, distended the small bowel 
with fluid, this was not seen with the larger less osmotically active molecule inulin. This 
passes through the small bowel without causing distension but is rapidly fermented once 
it enters the ascending colon, producing obvious gaseous distension 52. Interestingly IBS 
patients did not appear to show any greater physiological response to either fructose or 
inulin compared to healthy volunteers but had markedly greater symptoms, reflecting 
their known visceral hypersensitivity 53. The best correlation with patients’ composite 
symptom score (CSS) was with peak increase in colonic gas volume after inulin. A 
weaker correlation between SBWC and symptoms was seen after fructose in keeping 
with its greater impact in the small bowel. 
Many patients believe that bread causes symptoms particularly bloating and a low 
FODMAP diet often involves excluding normal bread which contains about 1% FODMAPs, 
mostly fructo-oligosaccharides including raffinose and stachyose  54. While this might 
lead to excess colonic gas and hence bloating / gas 4-6 hours after ingestion, the 
bloating developing immediately after eating is more likely due to gastric distension.  
MRI studies comparing equicaloric rice meal with whole meal bread showed that while 
the rice pudding meal separated into a solid and liquid phase, the whole meal bread 
formed a rather homogeneous mass with no clear separation of fluid and solid. While the 
rice meal allowed the stomach to sieve the meal and empty the fluid faster than the 
solid, sieving was not possible with the more homogeneous bread meal and as a 
consequence the gastric volume fell more slowly. In contrast once the wheat entered the 
small intestine it was rapidly absorbed and the SBWC was consistently lower than after 
the rice meal postprandially. This suggests than any sensation of bloating at this time 
was  more likely to come from the stomach than the small intestine55. 
Gluten is a key determinant of dough elasticity and thought to contribute to symptoms 
so we have investigated how it affects the upper intestinal processing of bread meals by 
comparing gluten free bread with bread with normal gluten content and a bread 
supplemented with 3% gluten. The gastric images showed the added gluten did produce 
a less homogeneous intra-gastric appearance  but this was not associated with any 
difference in gastric emptying and all meals showed the same pronounced drop in small 
bowel water postprandially 56.  Unexpectedly feeding gluten free bread for 2 days 
significantly increased the fasting transverse colonic volumes by 36% compared to 
normal bread, possibly reflecting the effect of the tapioca  and potato starches used to 
replace wheat in gluten free products. 
 
Impact of dietary fibre on small bowel contents 
Dietary fibre, which is widely used as a dietary treatment for constipation, comprises a 
range of very different materials often divided into soluble and insoluble forms. Precisely 
how these produce laxation and the role of the small bowel in this has been unclear. 
Ileostomy studies suggested that soluble fibre such as psyllium and gelling agents 
increase small bowel flow but the small bowel of ileostomists is rather atypical with 
abnormal mucosa and microbiota so it has been important to study this in intact 
humans. It is only recently that MRI has enabled us to complete this part of the picture. 
Psyllium appears to trap water in the small bowel, presumably by increasing viscosity 
thereby impairing convection and reducing access of water to the intestinal mucosa 
where absorption takes place. Conventional doses of 3.5 and 7 g psyllium three times 
daily with food, lead to increased post prandial  SBWC, which rises steadily during the 
day until a large (1000 kcal) meal stimulates ileal emptying, reducing SBWC back 
towards baseline (Figure 5)57. Our earlier studies with bran 58 and more recent studies 
comparing bran directly with psyllium and prickly pear extract 59 show similar increase in 
SBWC developing postprandially. The increase after bran appears to be more likely due 
to stimulation of secretion since unlike psyllium it shows little water trapping 60. 
The resulting ileal contents are emptied into the ascending colon after the second large 
meal which stimulates ileal emptying. This leads to an increase in the fluidity of the 
ascending colon contents. As already stated, T1 is a time constant reflecting the decay of 
magnetisation after excitation by radiofrequency energy pulses and increases as the 
colonic contents become more watery. During the psyllium study the T1 was significantly 
higher after both 3.5 g and 7 g psyllium being 631±37 and 779±48 msec respectively 
compared to the maltodextrin control  at 447±37msec. We validated the use of T1 
measurements as an assessment of colonic water content by showing that T1 of 
descending colon contents were well correlated with the % water of stool passed 
subsequently, Pearson’s r=0.65 61. 
Effect of phytochemicals 
While carbohydrate is the staple source of energy, much of what we eat is flavoured with 
plant products such as herbs and spices, all of which influence the processes of 
digestion. Rhubarb is an important ingredient of many Chinese herbal preparations and 
reported by ileostomists to increase ileal outflow 62. Imaging the bowel after rhubarb 
ingestion shows a large increase in SBWC, followed by a rise in ascending colon T1 63. 
Rhubarb is known to contain rhein, a mild cyotoxic substance, shown in animal studies to 
exert a laxative effect which can be blocked by indomethacin. Rhein stimulates 
prostaglandin 3 secretion and downregulates expression of Aquaporin 3 in cell lines 
which is a possible mechanism of its laxative effect 64.  Interestingly the same study also 
showed that lettuce which contains a milk-like latex, lactucarium, which like rhein is a 
mild cytotoxin also increases SBWC 65. It is likely that many green vegetables similarly 
increase SBWC and hence delivery of fluid to the colon with likely beneficial effects in 
preventing constipation. 
Abnormalities of small bowel in coeliac disease and scleroderma 
Both coeliac disease and scleroderma have a well defined appearance in barium contrast 
studies but as mentioned barium is a nonphysiological stimulus. MRI can demonstrate 
similar anatomical abnormalities such as dilated loops (Figure 6) with the potential to 
further understanding of pathophysiology (Lam et al  in press 2019). The dilated fasting 
loops are likely to reflect the effect of reduced migrating motor complexes and loss of 
their normal function of propelling meal residue into the colon. Whether increased fasting 
SBWC is associated with SIBO could be easily determined and would improve our 
understanding and management of these conditions. 
Abnormalities of small bowel in IBS 
One of the big surprises of recent MRI studies was the demonstration that IBS patients 
with diarrhoea (IBS-D) had less small bowel water than normal (Figure 6) 48;66. This was 
associated with accelerated mouth to caecum transit and anxiety 40, suggesting that 
psychological stress might be causing increased tone, leading to decreased SBWC.  
Previous human studies using a dichotomous  listening test as a stressor have shown 
that  psychological stress accelerates small bowel transit 67. Subsequent animal studies 
had suggested that this involved activation of the hypothalamic pituitary axis mediated 
by corticotrophin releasing hormone (CRH). CRH also acts peripherally to accelerate 
transit 68 and can be readily used in humans to mimic the effect of stress on the gut. A 
randomised placebo controlled trial (RCT) in healthy volunteers of an intravenous bolus 
of 100mcg  CRH  versus saline control showed that this reduced SBWC postprandially by 
an amount similar to that seen in IBS-D. CRH also increased the volume of the 
ascending colon in the following 3 hours suggesting that stress causes an increased 
inflow into the colon 69. Using the same study design but using a fructose meal we were 
also able to show not only that CRH constricted the small bowel but that this also 
enhanced the subsequent increase in ascending colon volumes showing how stress could 
exacerbate the impact of FODMAPs 70.  
While studies in IBS with constipation (IBS-C) show normal fasting and postprandial 
SBWC , when stressed by a large dose of osmotic laxative, the SBWC was higher in 
functional constipation than in IBS-C suggesting an impairment of motility with delay in 
transit of the osmotic bolus to the colon in this subgroup71. 
 
Effect of therapeutic interventions 
As described above MRI can be used to demonstrate the mode of action of psyllium. It 
has also been used to show that Ondansetron, a 5HT-3 receptor antagonist (5-HT3RA) 
shown to slow whole gut transit in IBS-D 72, increased fasting SBWC in intubated healthy 
volunteers while reducing antro-duodenal motility. This supports the idea that reduced 
fasting SBWC such as is seen in IBS-D could be an indicator of increased small bowel 
tonic or phasic contractions. 
Loperamide is known to slow whole gut transit and to be effective in treating diarrhoea 
but the precise mode of action has not been shown in intact humans. A RCT comparing 
two formulations of loperamide versus placebo in mannitol-induced small bowel secretion 
showed its impact on the small bowel, with reduced SBWC and delayed arrival of fluid in 
the ascending colon suggesting it enhanced absorption 73. 
Assessment of small bowel and colonic motility using MRI 
 The high quality images of the colon and the ability to acquire images in milliseconds 
has made it possible to produce cine images of the colonic wall over several minutes and 
to thus quantify colonic motility 71. A key requirement for this is the ability to allow 
image acquisition during free breathing by compensating for respiratory movement by 
means of an image registration technique. By deforming all the different images from 
the cine acquisition so that they best match a reference image (from the same dataset), 
it is possible to derive this deformation field information.  This information then allows 
tracking of any location in the bowel through the cine data, and provides information on 
the local expansion and contraction of each pixel in the image over the acquisition time, 
with large changes in expansion and contraction associated with higher motility.  
Summary metrics can then be used to quantify the amount of movement seen as a 
numerical comparison between different people or treatments.  The technique was first 
used to demonstrate reduced motility in Crohn’s ileitis74. The method has been validated 
by showing that it can detect the stimulatory and inhibitory effects of neostigmine and 
buscopan respectively on small bowel motility75. It has recently been used to show 
impaired small bowel motility in pseudo-obstruction and also to evaluate patients’ 
response to prokinetic neostigmine76. The method continues to evolve and more recently 
motility has been used to measure  the stimulatory effect of nutrients without the need 
to distend the bowel with  mannitol with good reproducibility77;78. 
Future studies 
MRI studies are highly patient acceptable and this makes it possible to perform repeated 
studies using RCT design, ideal for drug evaluation to provide early signal of 
effectiveness and mode of action. It also lends itself to mechanistic studies of the impact 
of different foods designed for specific function in both health and disease. We are 
currently developing MR suitable markers which could be used to more accurately assess 
small bowel transit times and hence assess flow. Future technical developments include 
the possibilities  of exploiting the effects of pH and redox potential  on the MR signal 
probing these potentially important parameters in health and disease. 
 
 
Legend for Figures 
Figure 1 MR images of small bowel during infusion of a balance saline mannitol solution 
used to validate the measurement of small bowel water content 
A)  Maximum intensity projection images of small bowel after sequential boluses of 
40ml mannitol-saline given via a nasoduodenal tube 
B)  Correlation between MRI measurement of small bowel water on the y axis and 
infused volume + baseline volume during nasoduodenal infusion of boluses of 
mannitol-saline solution showing excellent agreement between the 2 measures45 . 
 
 Figure 2 
Small bowel water content over time following ingestion of two iso-osmolar solutions of 
glucose 5% and mannitol 5%. There was a striking rise in water content with mannitol 
compared to the rapid absorption of the glucose solution 48. 
 
 
Figure 3 Effect of 1 L and 2 L Moviprep on Small Bowel Water Content (SBWC). 
A)  Chart showing SBWC in ml at varying time points. Ingestion finished at time 0  with 
1 hour allowed for 1L and 2 hours for 2 L of Moviprep. Scans thereafter were at hourly 
intervals for the next 4 hours (1 L) or 6 hours (2 L). There was a rapid increase in SBWC 
peaking immediately after  ingestion with a subsequent decline as fluid moved into the 
colon.  
 
 
B)  T2 weighted MR image showing water as bright pixels immediately after a 2 hour 
ingestion of 2 L of Moviprep. The stomach is dilated  and the small bowel distended 
with fluid, some of which has entered the colon filling and distending the ascending 
and transverse colon 49.  
 
Figure 4 Effect of mixed nutrient liquid and solid meal on small bowel water content 
(SBWC)   
Time profile of SBWC in ml against time after ingestion of orange juice and rice pudding 
mixed with jam with and without 15g bran flakes 48. Bran increased fluid in the second 
half of the study.  
 
Figure 5 Effect of psyllium on small bowel water content 
Small bowel water content during the study day during a RCT of psyllium 3.5 g and 7 g 
versus maltodextrin 14 g three time daily (shown by arrows) showing a rise in SBWC  
particularly after the second and third dose 61. 
 
Figure 6 MR images showing small bowel fluid in fasting subjects. Healthy controls (A) 
show little free water while both coeliac disease (B) and scleroderma (C) are 
characterised by dilated loops with increased small bowel water reflecting impaired 
fasting motility.  
 
Figure 7 Effect of irritable bowel syndrome with diarrhoea on small bowel water content 
 Small bowel water content fasting and after a 362 kcal rice pudding and bran test meal 
showing  the results from 26 IBS patients with diarrhoea ( lower line) who had 
consistently lower SBWC than 16 healthy volunteers (upper line). 
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